EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?

Milan Jagurinoski, Yanitsa Davidkova, Milena Stojcov-Jagurinoska, Gueorgui Balatzenko, Branimir Spassov, Margarita Guenova iD

Folia Medica · 2023

DOI: 10.3897/folmed.65.e98404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Medica, 2023. Verfasst von Milan Jagurinoski und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Myeloproliferative Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To compare the main features of patients with secondary acute myeloid leukemias (AMLs) after post-myelodysplastic syndrome (AML-post-MDS) or post-myeloproliferative neoplasms (AML-post-MPN) and myeloid blast crisis of chronic myeloid leukemia (CML-BC) vs. de novo AMLs with myelodysplastic characteristics ( dn -AML-MDS). Materials and methods : Bone marrow/peripheral blood samples of 94 patients with secondary AMLs (30 with AML-post-MDS, 20 with AML-post-MPN, and 14 with CML-BC) and 30 with dn -AML-MDS were included. Demographic, morphological, phenotypic, cytogenetic, and survival data were analyzed.

Results

Comparative analysis showed no differences in sex and age, except for the younger age in CML-BC ( p =0.005). Leukocytosis was a prevalent feature of CML-BC vs. AML-post-MPN, AML-post-MDS and dn -AML-MDS ( p <0.001). At leukemia onset, thrombocytopenia was characteristic of AML-post-MDS and dn -AML-MDS whereas normal PLT counts were found in AML-post-MPN and CML-BC ( p =0.001). Dysplasia in ≥2 lineages was observed in almost all dn -AML-MDS (96.8%) and AML-post-MDS (100%) compared to AML-post-MPN (33.3%) and none of the CML-BC ( p =0.001). Aberrant co-expression of 1-4 lymphoid-associated markers was detected in 67.5% of all patients, including CD7, CD19, CD56, and CD22. We found chromosome aberrations in 57.8% of patients, more frequently in dn -AML-post-MDS than in AML-post-MPN, CML-BC, and AML-post-MDS. While NPM1 mutations distribution was similar in the two MDS-related AML groups, FLT3-ITD was higher in AML-post-MDS (26.3%) than in dn -AML-MDS (4.5%) ( p =0.049). Regarding EVI1 , CML-BC (80%) and AML-post-MPN (37.5%) showed higher incidence of gene overexpression compared to AML-post-MDS (13.3%) and dn -AML-MDS (5.0%) ( p =0.001). Median time to leukemia was significantly shorter in AML-post-MDS (4.80±1.04 months) than in AML-post-MPN (20.3±2.86 months) and CML-BC (34.7±16.3 months) ( p =0.008), and median overall survival was poor in all groups.

Conclusions

Similarities and differences between patients with secondary AMLs may represent different biology which translates into different clinical course and may require different therapeutic approach in future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMyeloproliferative DisordersHumans

Stichwörter der Autor:innen

acute myeloid leukemia blast crisis myelodysplasia myeloproliferative disorder

Autor:innen und Institutionen

  • National Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria.

ORCID-Profile: Margarita Guenova

Zitieren

APA

Jagurinoski, M., Davidkova, Y., Stojcov-Jagurinoska, M., Balatzenko, G., Spassov, B., & Guenova, M. (2023). Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?. Folia Medica. https://doi.org/10.3897/folmed.65.e98404

Vancouver

Jagurinoski M, Davidkova Y, Stojcov-Jagurinoska M, Balatzenko G, Spassov B, Guenova M. Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?. Folia Medica. 2023. doi:10.3897/folmed.65.e98404

BibTeX
@article{Jagurinoski2023,
  author = {Jagurinoski, Milan and Davidkova, Yanitsa and Stojcov-Jagurinoska, Milena and Balatzenko, Gueorgui and Spassov, Branimir and Guenova, Margarita},
  title = {Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers?},
  journal = {Folia Medica},
  year = {2023},
  doi = {10.3897/folmed.65.e98404}
}
Kostenlos starten →